Wallington Asset Management, LLC Amgen Inc Transaction History

Wallington Asset Management, LLC

$718 Million
Q3 2024

A detailed history of Wallington Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wallington Asset Management, LLC holds 42,039 shares of AMGN stock, worth $12.4 Million. This represents 1.89% of its overall portfolio holdings.

Number of Shares

42,039

Previous 40,719 3.24%

Holding current value

$12.4 Million

Previous $12.7 Million 6.46%

% of portfolio

1.89%

Previous 1.94%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$309.38 - $337.38 $408,381 - $445,341	1,320 Added 3.24%	42,039 $13.5 Million
Q2 2024 Jul 22, 2024	BUY	$262.75 - $319.31 $174,728 - $212,341	665 Added 1.66%	40,719 $12.7 Million
Q1 2024 Apr 19, 2024	BUY	$268.87 - $324.56 $29,575 - $35,701	110 Added 0.28%	40,054 $11.4 Million
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $116,343 - $131,249	455 Added 1.15%	39,944 $11.5 Million
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $92,926 - $115,370	425 Added 1.09%	39,489 $10.6 Million
Q2 2023 Jul 19, 2023	BUY	$214.27 - $253.37 $107,563 - $127,191	502 Added 1.3%	39,064 $8.67 Million
Q1 2023 Apr 14, 2023	SELL	$225.79 - $275.2 $4,515 - $5,504	-20 Reduced 0.05%	38,562 $9.32 Million
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $125,966 - $160,055	550 Added 1.45%	38,582 $10.1 Million
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $42,871 - $48,351	191 Added 0.5%	38,032 $8.57 Million
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $79,594 - $88,575	345 Added 0.92%	37,841 $9.21 Million
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $130,684 - $144,571	596 Added 1.62%	37,496 $9.07 Million
Q4 2021 Jan 25, 2022	BUY	$198.88 - $227.6 $53,697 - $61,452	270 Added 0.74%	36,900 $8.3 Million
Q3 2021 Oct 20, 2021	SELL	$212.27 - $248.7 $75,355 - $88,288	-355 Reduced 0.96%	36,630 $7.79 Million
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $192,469 - $213,531	824 Added 2.28%	36,985 $9.02 Million
Q1 2021 Apr 16, 2021	SELL	$221.91 - $258.6 $47,710 - $55,599	-215 Reduced 0.59%	36,161 $9 Million
Q4 2020 Jan 12, 2021	SELL	$216.38 - $257.67 $29,860 - $35,558	-138 Reduced 0.38%	36,376 $8.36 Million
Q3 2020 Oct 16, 2020	BUY	$234.65 - $260.95 $46,930 - $52,190	200 Added 0.55%	36,514 $9.28 Million
Q2 2020 Jul 17, 2020	BUY	$197.81 - $242.74 $20,770 - $25,487	105 Added 0.29%	36,314 $8.57 Million
Q1 2020 Apr 15, 2020	BUY	$182.24 - $241.7 $5,467 - $7,251	30 Added 0.08%	36,209 $7.34 Million
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $17,974 - $23,104	95 Added 0.26%	36,179 $8.72 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $26,116 - $31,293	150 Added 0.42%	36,084 $6.98 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $70,014 - $82,072	420 Added 1.18%	35,934 $6.62 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $6.21 Million - $7 Million	-34,322 Reduced 49.15%	35,514 $6.75 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $56,731 - $66,223	-318 Reduced 0.45%	69,836 $13.6 Million
Q3 2018 Oct 15, 2018	BUY	$185.29 - $208.89 $39,837 - $44,911	215 Added 0.31%	70,154 $14.5 Million
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $27,398 - $30,774	-165 Reduced 0.24%	69,939 $12.9 Million
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $205,010 - $239,580	-1,210 Reduced 1.7%	70,104 $12 Million
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $89,458 - $99,952	-530 Reduced 0.74%	71,314 $12.4 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $12 Million - $13.7 Million	71,844	71,844 $13.4 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallington Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wallington Asset Management, LLC with notifications on news.

Account

Wallington Asset Management, LLC Amgen Inc Transaction History